Login
Super Investors Sands Capital Alternatives, LLC
SC

Sands Capital Alternatives, LLC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$695M
Positions
24
Quarter ended
September 30, 2026
Filed
November 13, 2026

Reported portfolio value by quarter (21 quarters reported)

$695M $299M
Q3 21 Q4 22 Q1 24 Q2 25 Q3 26

$663M in Q3 2021 → $695M now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
Alamar Biosciences Inc 20.7% Unchanged 4,230,926 $144M
NH Nu Hldgs Ltd 12.7% Trimmed 1.5% 6,991,934 $88.5M
Beta Bionics Inc 10.9% Added 7.8% 3,997,898 $75.9M
Spyglass Pharma Inc 9.4% Unchanged 2,500,012 $65M
Klaviyo Inc 8.7% Trimmed 2.6% 3,827,359 $60.2M
10x Genomics Inc 6.3% Unchanged 481,770 $43.5M
Inhibikase Therapeutics Inc 3.9% Unchanged 13,018,965 $26.8M
Cerebras Systems Inc 3.1% Added 273% 122,484 $21.8M
Doordash Inc 2.8% Trimmed 16% 107,301 $19.7M
Odyssey Therapeutics Inc 2.8% Unchanged 875,000 $19.4M
Freenome Inc 2.7% New 1,201,998 $18.9M
Coupang Inc 2.5% Trimmed 6.4% 1,244,409 $17.3M
Datadog Inc 2.5% Trimmed 22% 63,020 $17.3M
Samsara Inc 2.2% Trimmed 23% 395,621 $15.1M
Toast Inc 1.3% Trimmed 14% 314,907 $9.13M
Acumen Pharmaceuticals Inc 1.2% Unchanged 3,720,105 $8.26M
Snowflake Inc 1.1% Trimmed 6.4% 22,926 $7.78M
Tarsus Pharmaceuticals Inc 1.0% Unchanged 85,000 $6.68M
Servicetitan Inc 0.9% Trimmed 16% 91,101 $5.99M
Bioage Labs Inc 0.8% Unchanged 786,353 $5.58M
Monday Com Ltd 0.8% Trimmed 18% 67,182 $5.27M
Acrivon Therapeutics Inc 0.7% Unchanged 2,289,271 $4.69M
Candel Therapeutics Inc 0.6% Unchanged 405,837 $4.24M
Taysha Gene Therapies Inc 0.5% Unchanged 724,873 $3.53M

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q3 2026

quarter ended September 30, 2026 · filed November 13, 2026

Company Action Shares changed Value of change % of portfolio
Freenome Inc New +1,201,998 +$18.9M 2.7%
Cerebras Systems Inc Added +89,659 +$15.9M 3.1%
Beta Bionics Inc Added +289,855 +$5.5M 10.9%
Datadog Inc Trimmed −17,831 −$4.88M 2.5%
Samsara Inc Trimmed −120,037 −$4.58M 2.2%
Doordash Inc Trimmed −20,261 −$3.72M 2.8%
Klaviyo Inc Trimmed −100,787 −$1.59M 8.7%
Toast Inc Trimmed −49,972 −$1.45M 1.3%
NH Nu Hldgs Ltd Trimmed −103,018 −$1.3M 12.7%
Coupang Inc Trimmed −84,905 −$1.18M 2.5%

Showing the 10 largest of 14 changes.

Q2 2026

quarter ended June 30, 2026 · filed August 13, 2026

Company Action Shares changed Value of change % of portfolio
Alamar Biosciences Inc New +4,230,926 +$115M 18.7%
Odyssey Therapeutics Inc New +875,000 +$16.4M 2.7%
NH Nu Hldgs Ltd Added +557,183 +$7.44M 15.4%
Cerebras Systems Inc New +32,825 +$7.25M 1.2%
Coupang Inc Added +317,223 +$5.51M 3.8%
Klaviyo Inc Added +278,468 +$4.2M 9.7%
Doordash Inc Added +16,331 +$3.01M 3.8%
Toast Inc Added +63,232 +$1.76M 1.7%
Samsara Inc Trimmed −44,629 −$1.45M 2.7%
Servicetitan Inc Added +18,689 +$1.32M 1.3%

Showing the 10 largest of 15 changes.

Q1 2026

quarter ended March 31, 2026 · filed May 08, 2026

Company Action Shares changed Value of change % of portfolio
Spyglass Pharma Inc New +2,500,012 +$64.8M 15.4%
NH Nu Hldgs Ltd Trimmed −323,630 −$4.65M 22.3%
Samsara Inc Added +94,097 +$2.98M 4.2%
Coupang Inc Added +141,667 +$2.67M 4.5%
Doordash Inc Added +15,613 +$2.34M 4.0%
Beta Bionics Inc Added +137,930 +$1.38M 8.8%
Acumen Pharmaceuticals Inc Added +303,030 +$715K 2.1%

Q4 2025

quarter ended December 31, 2025 · filed February 13, 2026

Company Action Shares changed Value of change % of portfolio
Servicetitan Inc New +89,856 +$9.57M 1.8%
CH Crowdstrike Hldgs Inc Exited −15,615 −$7.66M —
Tarsus Pharmaceuticals Inc Trimmed −85,000 −$6.96M 1.3%
NH Nu Hldgs Ltd Trimmed −314,035 −$5.26M 22.2%
Toast Inc Added +145,043 +$5.15M 2.1%
Samsara Inc Trimmed −132,724 −$4.71M 3.2%
Datadog Inc Trimmed −32,914 −$4.48M 2.3%
Klaviyo Inc Added +134,613 +$4.37M 22.9%
Inhibikase Therapeutics Inc Added +2,068,965 +$4.24M 5.1%
Coupang Inc Added +75,418 +$1.78M 4.0%

Showing the 10 largest of 13 changes.

Q3 2025

quarter ended September 30, 2025 · filed November 13, 2025

Company Action Shares changed Value of change % of portfolio
Doordash Inc Trimmed −291,060 −$79.2M 5.4%
Samsara Inc Added +160,429 +$5.98M 4.9%
Coupang Inc Trimmed −54,025 −$1.74M 5.6%
Figma Inc New +18,286 +$948K 0.2%

Q2 2025

quarter ended June 30, 2025 · filed August 13, 2025

Company Action Shares changed Value of change % of portfolio
Samsara Inc Added +185,053 +$7.36M 3.4%
Beta Bionics Inc Added +466,331 +$6.79M 10.2%
Uipath Inc Exited −395,855 −$4.08M —
Monday Com Ltd Added +8,428 +$2.65M 3.6%
Klaviyo Inc Added +71,550 +$2.4M 23.2%
Toast Inc Trimmed −54,007 −$2.39M 1.4%
Coupang Inc Added +5,555 +$166K 5.0%
NH Nu Hldgs Ltd Added +11,079 +$152K 19.4%
Doordash Inc Added +498 +$123K 18.5%
Datadog Inc Added +777 +$104K 3.1%

Showing the 10 largest of 12 changes.

Q1 2025

quarter ended March 31, 2025 · filed May 14, 2025

Company Action Shares changed Value of change % of portfolio
Beta Bionics Inc New +3,103,782 +$38M 9.3%
Uipath Inc Trimmed −1,188,822 −$12.2M 1.0%
Doordash Inc Trimmed −26,639 −$4.87M 17.0%
Samsara Inc Added +54,742 +$2.1M 2.4%
Datadog Inc Added +20,142 +$2M 2.9%
Coupang Inc Trimmed −81,236 −$1.78M 4.5%
Snowflake Inc Trimmed −12,179 −$1.78M 1.0%
NH Nu Hldgs Ltd Added +143,196 +$1.47M 17.9%
Klaviyo Inc Trimmed −27,179 −$822K 25.5%
Toast Inc Trimmed −20,919 −$694K 1.7%

Showing the 10 largest of 14 changes.

Q4 2024

quarter ended December 31, 2024 · filed February 13, 2025

Company Action Shares changed Value of change % of portfolio
Inhibikase Therapeutics Inc New +10,950,000 +$35.6M 7.7%
Coupang Inc Added +912,781 +$20.1M 4.4%
NH Nu Hldgs Ltd Added +1,522,357 +$15.8M 15.8%
Datadog Inc Added +96,382 +$13.8M 3.0%
Monday Com Ltd New +48,278 +$11.4M 2.5%
Snowflake Inc Trimmed −69,297 −$10.7M 1.3%
Samsara Inc Added +195,518 +$8.54M 1.9%
Toast Inc Added +227,077 +$8.28M 1.8%
CH Crowdstrike Hldgs Inc Added +16,879 +$5.78M 1.3%
Uipath Inc Added +429,431 +$5.46M 4.4%

Showing the 10 largest of 15 changes.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support